TrialJournal of nuclear medicine : official publication, Society of Nuclear Medicine2012

Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with metastatic prostate cancer.

Steve Y Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.